Table 2.
Knowledge gaps on FGS | Research needs to bring FGS out of neglect |
---|---|
Measure the global burden of FGS | ➔ Conduct burden of disease studies across S. haematobium endemic settings ➔ Develop a framework to accurately estimate the disability weights associated with FGS including associated complications and morbidity. |
Explore the pathophysiological and epidemiological associations of FGS with other SRH conditions | ➔ Conduct larger longitudinal cohort studies to understand the temporal association between FGS and other SRH conditions, as well as the shared risk factors |
Further validate scalable, affordable, accurate and user-friendly diagnostic strategies against a validated gold standard. | ➔ Define a reference standard of care for FGS diagnosis that can be used across studies and settings for comparison of diagnostic test results |
Understand the impact of praziquantel treatment on FGS clinical outcomes and genital and sexual signs and symptoms | ➔ Conduct randomized controlled trials to understand the effect of praziquantel for treating FGS across age groups and endemic settings |
Strategies to implement FGS control strategies outside research settings | ➔ Conduct further costing studies to understand the affordability of different control strategies. ➔ Evaluate the cost-effectiveness of different FGS control strategies to inform effective implementation by the health system |
Evaluate an integrated approach for FGS control within the SRH agenda | ➔ Conduct further studies to understand the affordability, cost-effectiveness, coverage and acceptability of integrated control strategies for FGS and SRH conditions. |